Back to mobile site

More on ANIX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (9/29/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Anixa Biosciences (NQ:ANIX)
Delayed: 2.47 -0.01 (0.4%)
Prev. Close $2.48  
Open$2.49 
52 Wk High$ 
52 Wk Low$ 
Day High$2.55 
Day Low$2.41 
P/E N/A  
EPS$ 
Volume145,867 


Jun 12, 2026 06:52 AM H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)
Jun 11, 2026 09:05 AM Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
Jun 10, 2026 04:16 PM Form 10-Q Anixa Biosciences Inc For: Apr 30
Jun 1, 2026 09:00 AM Anixa receives Canadian patent allowance for ovarian cancer vaccine
Jun 1, 2026 09:00 AM Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance
May 11, 2026 11:48 AM /C O R R E C T I O N -- Anixa Biosciences, Inc./
May 11, 2026 08:55 AM Anixa Biosciences reports patient survival data from cancer therapy trial
May 11, 2026 08:55 AM Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy
May 1, 2026 09:15 AM Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
May 1, 2026 09:00 AM Anixia Biosciences and OwlTing Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
View All Articles

Entities mentioned with ANIX

View All Entities